In this research, we investigated the expression of MAGEA11 in gastric cancer and used bioinformatics analysis to evaluate its correlation with the prognosis and immune infiltration of gastric cancer patients and the sensitivity to different chemotherapeutic drugs. This evidence concerns the gene MAGEA11 and gastric cancer.